AI cancer cures slowed by chip shortage, says UK's biggest tech boss
Summary
The CEO of Arm Holdings, Rene Haas, said artificial intelligence (AI) will help find a cure for cancer in our lifetime, but the current chip shortage is slowing AI progress. Haas also predicted widespread use of humanoid robots within five years, powered by advanced chips designed by Arm.Key Facts
- Rene Haas is the CEO of Arm Holdings, a major UK-based chip design company.
- AI is expected to solve complex problems like modeling cancer’s effect on DNA, beyond what humans can do today.
- A shortage of semiconductor chips is slowing down AI development and the building of data centers.
- Arm chips are used in billions of devices worldwide, including phones and cars.
- AI-powered humanoid robots are predicted to become common in about five years.
- Arm’s technology is used in half of AI data centers globally, showing its significant market influence.
- Demand for Arm’s new AI-focused chips, including one requested by Meta (Facebook’s owner), has exceeded $2 billion since March.
- AI in medicine will focus on training with accurate data from patient samples, which can speed up creating new treatments.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
